Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90
Published February 26, 2025 · Recall initiated: February 4, 2025
Summary
FDA records drug Class II recall D-0229-2025, published February 26, 2025 and initiated February 4, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 1266 bottles; Lot: Lot#: BC20223A, Exp. March 31, 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
What to do
Voluntary: Firm initiated · Letter
Get an email if SILODOSIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SILODOSIN
- Manufacturer
- AvKARE
- Distributor
- USA Nationwide
- Lot
- Lot#: BC20223A, Exp. March 31, 2025.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDAPhenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as aFebruary 26, 2025
- FDALorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDAAtomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark PharmaceuticalsFebruary 26, 2025
- FDALorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDAAtomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark PharmaceuticalsFebruary 26, 2025
Questions about this recall
Was Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90 recalled?
Yes. FDA published recall D-0229-2025 on February 26, 2025. Reported hazard: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SILODOSIN.